Work

Abstract CT125: A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-ct125

Authors: Patrick A. Ott, Ramaswamy Govindan, Aung Naing, Terence W. Friedlander, Kim Margolin, Jessica J. Lin, Nina Bhardwaj, Matthew D. Hellmann, Lakshmi Srinivasan, Joel Greshock, Melissa Moles, Richard B. Gaynor, Matthew J. Goldstein, Siwen Hu-Lieskovan

Institutions: Dana-Farber Cancer Institute, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, City Of Hope National Medical Center, Massachusetts General Hospital, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, University of California, Los Angeles

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2886663063

Cites:

Cited by: 9

Related to: 10